4.6 Article

Anaemia and pathologic complete response rate according to carboplatin dose in HER2+breast cancer treated with neoadjuvant TCHP

Related references

Note: Only part of the references are listed.
Article Oncology

Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021

H. J. Burstein et al.

Summary: The 17th St Gallen International Breast Cancer Consensus Conference in 2021 was held virtually, with over 3300 participants discussing key issues related to early breast cancer diagnosis and treatment. The conference emphasized customized recommendations for breast cancer treatment, highlighting the importance of individualized clinical features in patient care.

ANNALS OF ONCOLOGY (2021)

Article Oncology

Breast Cancer, Version 3.2020

William J. Gradishar et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)

Review Oncology

Cancer- and Chemotherapy-Induced Anemia

George M. Rodgers et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2012)

Article Biotechnology & Applied Microbiology

HER-dimerization inhibitors: evaluating pertuzumab in women's cancers

Katrin Kristjansdottir et al.

EXPERT OPINION ON BIOLOGICAL THERAPY (2010)

Article Oncology

Management of anaemia in patients with breast cancer: role of epoetin

RC Leonard et al.

ANNALS OF ONCOLOGY (2005)